Facilitated By

San Antonio Medical Foundation

A Collaboration of the San Antonio Bioscience and Medical Research Community

A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of Acalabrutinib In Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone (R-CHOP) In Subjects >65 Years With Previously Untreated Non-Germinal Center Diffuse

The primary objective of the study is to evaluate the effect of adding acalabrutinib to R-CHOP for progression-free survival in previously untreated non-germinal center diffuse large B-cell lymphoma.

Brooke Army Medical Center
Email for information
More Info
CLINICAL DEVELOPMENT OF RHENIUM NANOLIPOSOMES (RNL 186) FOR GLIOBLASTOMA

Glioblastoma (GBM) is the most common and most aggressive of the primary malignant brain tumor in adults,with a median overall survival of 19.6 months following multi-modality therapy. The main limiting factor indelivering a tumoricidal radiation dose is the toxicity to surrounding brain. Therapeutic radionuclides, due to ashort tissue path and differences in radiobiology, have the potential to extend the therapeutic window for radiationin GBM.

UT Health San Antonio
Brenner, Andrew
More Info